Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 2 |
2006 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
Clin Pharmacol Ther. 2008 Sep;84(3):320-5. doi: 10.1038/clpt.2008.57. Epub 2008 Apr 2.
Clin Pharmacol Ther. 2008.
PMID: 18388868
Clinical Trial.
No abstract available.
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.
Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF.
Malaiyandi V, et al.
Mol Psychiatry. 2006 Apr;11(4):400-9. doi: 10.1038/sj.mp.4001794.
Mol Psychiatry. 2006.
PMID: 16402128
Clinical Trial.
Item in Clipboard
Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial.
Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, Benowitz N.
Lerman C, et al.
Ann Intern Med. 2004 Mar 16;140(6):426-33. doi: 10.7326/0003-4819-140-6-200403160-00009.
Ann Intern Med. 2004.
PMID: 15023708
Clinical Trial.
Item in Clipboard
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial.
Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini WH.
Lerman C, et al.
Pharmacogenomics J. 2004;4(3):184-92. doi: 10.1038/sj.tpj.6500238.
Pharmacogenomics J. 2004.
PMID: 15007373
Clinical Trial.
Item in Clipboard
Cite
Cite